DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Zinman B, Wanner C, Lachin JM. et al.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
N Engl J Med 2015;
373 (22) 2117-2128
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.